CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 144 enrolled
Drug / intervention
Remote Care Follow updevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01482598
NCT01482598N/ACompleted

COR HF - Clinical Benefits in Optimized Remote HF Patient Management

Abbott Medical Devices·interventional·Posted Nov 30, 2011·Updated Nov 16, 2020

In Brief

A clinical study evaluating Remote Care Follow up for Congestive Heart Failure Treated. Completed, enrolled 144 participants across 18 sites.

Detailed Summary

The Study Purpose is to demonstrate the superiority of optimized remote patient management compared to optimized standard care in the management and prognosis of heart failure, in the prevention of recurrent atrial tachycardia or atrial fibrillation episodes and in the reduction of inappropriate shock therapies. The remote care allows early intervention in terms of drug therapy adjustment and cardiac resynchronization therapy (CRT-D) device reprogramming.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 30, 2011
Enrollment StartOct 1, 2011
Primary CompletionAug 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 14.6 years ago

Interventions

Remote Care Follow updevice

Patient device is checked daily through remote transmitter (Merlin@Home) and every 6 month a complete transmission with all device data is performed